Life Sciences: Product Liability

About

Provided by DAC Beachcroft LLP

We are involved in the vast majority of current substantive product liability cases; including PIP Breast Implant Litigation and metal-on-metal hip replacement products claims.

The client base includes instructions in respect of both liability and regulatory aspects arising from medical devices, clinical trials, consumer healthcare goods as well as pharma products. The advice we provide to the Life Sciences sector extends throughout the life cycle of a product from R&D, approval and licensing, pharmacovigilance and compliance issues and claims. We advise on labelling, advertising, representations to regulatory bodies and comparative claims for complex healthcare products.

We are instructed in a large number of claims arising from clinical trials as well as advising on coverage issues for all the main insurers who operate in the life sciences sector.

Aside from product liability and regulatory issues, the firm also advises life science clients in respect of intellectual property, brand management, clinical trial agreements, commercial contracts and corporate finance.

Recent work highlights

• Defended the majority of significant pharmaceutical/medical product liability cases in the UK over the last 40 years
• Landmark product liability cases have traditionally arisen in the pharmaceutical/healthcare sector due to their significant and repercussive nature
• We also have 35 years expertise in defending contaminated blood litigation claims for the NHS and National Blood Service